UnitedHealth (NYSE: UNH) just shocked Wall Street — posting a stronger-than-expected earnings report and raising its profit outlook for the year under returning CEO Stephen Hemsley. After months of turbulence from rising medical costs and regulatory scrutiny, the healthcare giant reported Q3 adjusted earnings of $2.92 per share, beating analyst estimates of $2.79. UnitedHealth also raised its full-year profit forecast to at least $16.25 per share, above both its prior outlook and consensus expectations. The company’s medical loss ratio came in at 89.9%, right on target, while Optum Rx — its pharmacy benefit manager — reported a 16% jump in revenue to $39.7 billion thanks to higher prescription volumes. Morningstar called it a “sign of stability” for a company that’s been battling cost pressure and investor skepticism all year. Shares rose over 3% premarket following the announcement. #UnitedHealth #Earnings #UNH 🖥️ Try Benzinga Pro FREE with a 14 day trial: benzinga....